One BioMed

One BioMed

One BioMed is a startup spinoff from A*STAR's Institute of Microelectronics, developing in vitro diagnostic platforms to address global health needs for decentralised.

About One BioMed

One BioMed is a startup spinoff from A*STAR's Institute of Microelectronics, developing in vitro diagnostic platforms to address global health needs for decentralised, point-of-care (POC) diagnostic testing. The company's first flagship product is an affordable, simple and integrated diagnostic device that can quickly detect infectious diseases based on a unique silicon biophotonic technology platform.

Team

Funding

INVESTOR
STAGE
AMOUNT
DATE

Singapore

See all investors
Round: Series A
Round Size: US$5M
Date: Jul 2019